ABT

Abbott Labs and Abbvie: Should Dividend Investors Hold?

Now that Abbott Laboratories has split into Abbott and AbbVie, here's a look at each of the new parts, and what dividend investors should look for. More

Dow Delivers Despite Iffy Earnings — Tuesday’s Market Recap

The Dow Jones powered ahead Tuesday despite some less-than-splendid earnings from Verizon and Johnson & Johnson. Also, Google impressed after hours. More

One Sector in Poor Health

Healthcare has significantly under-performed against the rest of the market, but there are tradable opportunities because of it More

AbbVie’s August Options Are a Steal

Options traders should take a longer-term tack with Abbott Labs spinoff AbbVie. Here are a couple options that look like compelling values. More

Spinoff Mania Is Winding Down (And Good Riddance!)

Sooner rather than later, investors will wake up to the reality of the spinoff boom: These deals aren't all "unlocking value." More

ETF Alternatives for Last Week’s Hot Stocks

Some of InvestorPlace's top stock picks in energy, dividend, pharmaceutical, home furnishings and financial stocks can be wrapped up into exchange-traded funds. More

Sector Scan: Hospital Supply and Management

Health care stocks are ending on a strong note this year, a trend that will likely continue. Here's the best and worst in the hospital supply and management areas. More